Live Breaking News & Updates on Committee On Genetic Manipulation

Stay updated with breaking news from Committee on genetic manipulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Serum Institute gets DCGI's nod to manufacture Sputnik V in India for test, analysis

"The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions," an official source said. ....

Committee On Genetic Manipulation , Gamaleya Research Institute Of Epidemiology , Serum Institute , Serum Institute Of India , Department Of Biotechnology , Gamaleya Research Institute , Review Committee , Genetic Manipulation , Sputnik V , குழு ஆன் ஜெநெடிக் கையாளுதல் , சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , துறை ஆஃப் உயிரி தொழில்நுட்பவியல் , விமர்சனம் குழு , ஜெநெடிக் கையாளுதல் , ஸ்பட்நிக் வ் ,

Serum Institute gets DCGI nod to manufacture Sputnik V COVID-19 vaccine in India

SII plans to seek restricted emergency use permission of the vaccine in India.
The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said on Friday.
The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. “The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions,” an official source said. ....

Committee On Genetic Manipulation , Gamaleya Research Institute Of Epidemiology , Serum Institute , Serum Institute Of India , Department Of Biotechnology , Gamaleya Research Institute , Review Committee , Genetic Manipulation , Lockdown Extension , Single Day Spik E , Covid 19 Vaccine , Health Ministry , Indian Council For Medical Research , Coronavirus Vaccine , Risk Of Deaths , Coronavirus Cases , Covid Test , Coronavirus Tests , Testing Facilities , Covid Treatment , Personal Protective Equipment , Coronavirus Detection , Covid 19 , Sars Cov 2 Virus , Sars Cov 2 , Coronavirus Lockdown ,

DCGI approves Serum's request to manufacture Sputnik V COVID-19 vaccine in India

Pune-based SII has partnered with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, in Russia for developing Sputnik V COVID-19 vaccine in India at its licensed facility in Hadapsar. ....

United Kingdom , Committee On Genetic Manipulation , Gamaleya Research Institute Of Epidemiology , Serum Institute , Serum Institute Of India , Department Of Biotechnology , Drugs Controller General , Russian Sputnik , Gamaleya Research Institute , Review Committee , Genetic Manipulation , Sputnik V , Sputnikv Vaccine , Putnikv Sii , Erum Institute Sputnikv India , Cgi Sputnikv Vaccine India , Ii Manufacture , Ii Sputnikv In India , Ii Russia Vaccine , Erum Institute Russian Vaccine , Russia Vaccine , ஒன்றுபட்டது கிஂக்டம் , குழு ஆன் ஜெநெடிக் கையாளுதல் , சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , துறை ஆஃப் உயிரி தொழில்நுட்பவியல் ,

Serum Institute gets DCGI's nod to manufacture Covid jab Sputnik V in India | India News

India News: NEW DELHI: The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik Covid-19 vaccine in India for examination,. ....

Committee On Genetic Manipulation , Gamaleya Research Institute Of Epidemiology , Serum Institute , Serum Institute Of India , Department Of Biotechnology , Gamaleya Research Institute , Review Committee , Genetic Manipulation , Ndia News , Ndia News Today , Oday News , Google News , Reaking News , Sputnik V , Dr Reddys Laboratories , குழு ஆன் ஜெநெடிக் கையாளுதல் , சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , துறை ஆஃப் உயிரி தொழில்நுட்பவியல் , விமர்சனம் குழு , ஜெநெடிக் கையாளுதல் , ஸ்பட்நிக் வ் , டாக்டர் ரேட்திச் ஆய்வகங்கள் ,

SII wants ''indemnity'' for all vaccine makers; seeks nod to manufacture Sputnik-V

Technology > Biotech & pharma
04 June 2021
Serum Institute of India (SII), the maker of Covishield, the Indian name for Oxford-AstraZeneca s vaccine against the Wuhan virus, has sought indemnity for vaccine failures or side effects on lines demanded by foreign vaccine companies like Pfizer, saying that the government should apply “same rules for all”.
Covishield-maker Serum Institute of India (SII) has asked for indemnity from liability for vaccine makers, whether Indian or foreign, after Pfizer and Moderna have sought protection from litigation.
The Adar Poonawalla-led SII, which is involved in the trials of three new anti-Coronavirus vaccines, has also sought approval from the Drug Controller General of India (DCGI) for the manufacture of the Russian vaccine Sputnik-V. ....

United Kingdom , Committee On Genetic Manipulation , Gamaleya Research Institute Of Epidemiology , National Expert Group On Vaccine Administration , Serum Institute Of India , Department Of Biotechnology , Serum Institute , Drug Controller General , Emergency Use Authorisation , National Expert Group , Vaccine Administration , Gamaleya Research Institute , Review Committee , Genetic Manipulation , Omain B , ஒன்றுபட்டது கிஂக்டம் , குழு ஆன் ஜெநெடிக் கையாளுதல் , சீரம் நிறுவனம் ஆஃப் இந்தியா , துறை ஆஃப் உயிரி தொழில்நுட்பவியல் , சீரம் நிறுவனம் , மருந்து கட்டுப்படுத்தி ஜநரல் , தேசிய நிபுணர் குழு , விமர்சனம் குழு , ஜெநெடிக் கையாளுதல் ,